The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2026

Filed:

Nov. 10, 2021
Applicant:

University of South Florida, Tampa, FL (US);

Inventors:

Subhra Mohapatra, Lutz, FL (US);

Shyam S. Mohapatra, Lutz, FL (US);

Karthick Mayilsamy, Tampa, FL (US);

Eleni Markoutsa, Tampa, FL (US);

Assignee:

University of South Florida, Tampa, FL (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/02 (2006.01); A61K 9/00 (2006.01); A61K 35/28 (2015.01); A61K 38/17 (2006.01); A61K 38/19 (2006.01); A61K 47/59 (2017.01); A61K 47/69 (2017.01); A61K 48/00 (2006.01); A61P 25/28 (2006.01); C07H 21/04 (2006.01);
U.S. Cl.
CPC ...
A61K 38/195 (2013.01); A61K 9/0019 (2013.01); A61K 9/0043 (2013.01); A61K 35/28 (2013.01); A61K 38/1793 (2013.01); A61K 47/595 (2017.08); A61K 47/6931 (2017.08); A61K 48/0041 (2013.01); A61P 25/28 (2018.01);
Abstract

Compositions and methods for treating traumatic brain injury (TBI) are presented. Novel dendriplexes are formed from poly(amidoamine) (PAMAM) dendrimers complexed with shRNA encoding DNA plasmids encapsulating shRNA encoding chemokine ligand 20 (CCL20) gene, chemokine receptor 6 (CCR6) gene, or a combination thereof. The dendriplexes are dually administered, both intranasally and intravenously, prior to administration of stem cells, such as human mesenchymal stem cells (hMSCs) for the treatment of traumatic brain injury (TBI). Administration of the dendriplexes prior to stem cell administration resulted in a decrease in neurodegeneration, neuroinflammation, microgliosis and astrogliosis. In addition, a synergistic increase in brain derived trophic factor (BDNF) was shown by administration of the combination of dendriplex and stem cell administration.


Find Patent Forward Citations

Loading…